Very positive Ann. I am in now: Sold out my MSB and bought almost 7 times more CYP. Less risk I think because if MSB trial is “successful”, then CYP will rise too on stem cell association. If MSB results are not good or hijacked by USA then high risk of MSB sp fall but less relevance to CYP plans or effect on sp.
My risk averse opinion only, dyor.
Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial, page-119
-
- There are more pages in this discussion • 377 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.32M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $58.84K | 310.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 33236 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 163350 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |